We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+0.61%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$14.7B
AUM Growth
+$1.55B
Cap. Flow
-$42.4M
Cap. Flow %
-0.29%
Top 10 Hldgs %
33.58%
Holding
2,110
New
660
Increased
423
Reduced
368
Closed
648

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$231M
2
COP icon
ConocoPhillips
COP
+$114M
3
AAPL icon
Apple
AAPL
+$80.8M
4
BDX icon
Becton Dickinson
BDX
+$68.3M
5
SHW icon
Sherwin-Williams
SHW
+$62.8M

Sector Composition

Rank Sector Weight
1 Healthcare 10.2%
2 Technology 10.13%
3 Utilities 6.69%
4 Consumer Discretionary 6.52%
5 Industrials 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANNX icon
1501
Annexon
ANNX
$961M
-315,155
Closed -$2.26M
APAM icon
1502
Artisan Partners
APAM
$3B
-58,560
Closed -$2.68M
APEI icon
1503
American Public Education
APEI
$835M
-12,194
Closed -$173K
APLT
1504
DELISTED
Applied Therapeutics
APLT
-60,795
Closed -$413K
APP icon
1505
Applovin
APP
$102B
-51,828
Closed -$3.59M
APPN icon
1506
Appian
APPN
$2.74B
-27,814
Closed -$1.11M
APPS icon
1507
Digital Turbine
APPS
$1.32B
-149,077
Closed -$391K
AQST icon
1508
Aquestive Therapeutics
AQST
$585M
-52,168
Closed -$222K
AR icon
1509
Antero Resources
AR
$11.7B
-941,864
Closed -$27.3M
ARES icon
1510
Ares Management
ARES
$31.9B
-72,548
Closed -$9.65M
ARLO icon
1511
Arlo Technologies
ARLO
$1.41B
-147,605
Closed -$1.87M
ARW icon
1512
Arrow Electronics
ARW
$10.7B
-57,075
Closed -$7.39M
ASAN icon
1513
Asana
ASAN
$2.21B
-140,746
Closed -$2.18M
ASML icon
1514
ASML
ASML
$677B
-2,391
Closed -$2.32M
ASO icon
1515
Academy Sports + Outdoors
ASO
$2.84B
-18,818
Closed -$1.27M
ASPN icon
1516
Aspen Aerogels
ASPN
$430M
-28,673
Closed -$505K
ASTS icon
1517
AST SpaceMobile
ASTS
$20.6B
-111,135
Closed -$322K
ATHM icon
1518
Autohome
ATHM
$2.56B
-27,544
Closed -$722K
ATNI icon
1519
ATN International
ATNI
$477M
-7,867
Closed -$248K
ATOS icon
1520
Atossa Therapeutics
ATOS
$25.3M
-1,731
Closed -$47K
ATRO icon
1521
Astronics
ATRO
$3.35B
-28,884
Closed -$458K
AVAV icon
1522
AeroVironment
AVAV
$8.14B
-12,704
Closed -$1.95M
AVD icon
1523
American Vanguard Corp
AVD
$67.9M
-43,237
Closed -$560K
AVNT icon
1524
Avient
AVNT
$4.1B
-12,541
Closed -$544K
AVPT icon
1525
AvePoint
AVPT
$2.83B
-257,383
Closed -$2.04M

Similar funds

Michael Gelband's Q2 2024 Portfolio in Review

As of Q2 2024, Michael Gelband held 2,110 positions worth $14.7B, up 12% from $13.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Michael Gelband's Q2 2024 filing shows 660 new, 423 increased, 368 reduced and 648 closed positions. Its largest new stake was Coca-Cola: 936,563 shares worth $59.6M. The largest sale was NVIDIA, an estimated $351M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, up from 6.9% a quarter earlier, followed by Technology and Utilities.

  • Michael Gelband's largest Q2 2024 buy was Coca-Cola: 936,563 shares worth $59.6M.
  • Michael Gelband added most to Amazon in Q2 2024, an estimated $231M increase.
  • Michael Gelband's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $351M.
  • Michael Gelband fully exited Global Payments in Q2 2024, selling an estimated $202M.
  • Michael Gelband's ten largest holdings make up 34% of its $14.7B portfolio in Q2 2024.
  • Michael Gelband opened 660 new positions and closed 648 in Q2 2024.
  • Michael Gelband's portfolio value rose 12% quarter-over-quarter to $14.7B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.